Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China · Delayed Price · Currency is CNY 15.79
-0.56 (-3.43%)
Apr 9, 2026, 2:45 PM CST
Cisen Pharmaceutical Revenue
In the year 2025, Cisen Pharmaceutical had annual revenue of 3.44B CNY, down -13.48%. Cisen Pharmaceutical had revenue of 860.94M in the quarter ending December 31, 2025, a decrease of -12.09%.
Revenue
3.44B
Revenue Growth
-13.48%
P/S Ratio
2.15
Revenue / Employee
1.04M
Employees
3,302
Market Cap
7.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.44B | -536.86M | -13.48% |
| Dec 31, 2024 | 3.98B | -480.78M | -10.77% |
| Dec 31, 2023 | 4.46B | 396.26M | 9.75% |
| Dec 31, 2022 | 4.07B | 283.50M | 7.49% |
| Dec 31, 2021 | 3.78B | 108.43M | 2.95% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Northeast Pharmaceutical Group | 7.07B |
| Hunan Jiudian Pharmaceutical | 3.05B |
| Jiangsu Lianhuan Pharmaceutical | 2.60B |
| Shandong Wit Dyne Health | 2.36B |
| Sunflower Pharmaceutical Group Co.,Ltd | 2.09B |
| Zhejiang Garden Biopharmaceutical | 1.24B |
| Beijing Sun-Novo Pharmaceutical Research | 1.22B |
| Hainan Haiyao | 825.66M |